These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical conferences at the Johns Hopkins Hospital. Post-transfusion hepatitis. Johns Hopkins Med J; 1981 Jul; 149(1):45-9. PubMed ID: 6788994 [No Abstract] [Full Text] [Related]
3. Current status of posttransfusion hepatitis. Alter HJ; Holland PV; Purcell RH Pathobiol Annu; 1980; 10():135-56. PubMed ID: 6777742 [No Abstract] [Full Text] [Related]
4. [Selection of donors in the prevention of post-transfusion viral hepatitis]. Massaro AL Riv Emoter Immunoematol; 1985; 32(2):156-9. PubMed ID: 3937210 [No Abstract] [Full Text] [Related]
5. [Clinical picture and outcomes of post-transfusion viral hepatitis non-A, non-B and B]. Favorov MO; Bugaeva NP; Ketiladze ES Sov Med; 1985; (6):97-100. PubMed ID: 3933126 [No Abstract] [Full Text] [Related]
6. Patterns of viral hepatitis in Hong Kong. Leung NW Br J Hosp Med; 1997 Aug 20-Sep 2; 58(4):166-9. PubMed ID: 9373408 [TBL] [Abstract][Full Text] [Related]
7. [Diagnosis and prevention of non-A, non-B viral hepatitis]. Suzuki S Nihon Naika Gakkai Zasshi; 1990 Mar; 79(3):300-3. PubMed ID: 2110234 [No Abstract] [Full Text] [Related]
9. [Diagnosis and prevention of viral hepatitis]. Deinhardt F Med Klin; 1980 Jan; 75(1):2-9. PubMed ID: 6767903 [No Abstract] [Full Text] [Related]
10. [Blood transfusion and hepatitis: hepatitis C virus detection]. Ranki M; Ebeling F Duodecim; 1990; 106(2):147-9. PubMed ID: 2106428 [No Abstract] [Full Text] [Related]
11. [Contribution to the task of reducing the incidence of post transfusion non-A, non-B hepatitis]. Hernández Sánchez MC; Vila Enriquez P; Alvarez Hernández M Sangre (Barc); 1989 Jun; 34(3):248-9. PubMed ID: 2503897 [No Abstract] [Full Text] [Related]
12. [Prevention of post-transfusional hepatitis]. Hernández JM Sangre (Barc); 1988 Jun; 33(3):242. PubMed ID: 3140399 [No Abstract] [Full Text] [Related]
13. [Obtaining protein fractions from human blood which are safe from the viewpoint of hepatitis transmission]. Stephan W Vnitr Lek; 1980 Jan; 26(1):59-62. PubMed ID: 6766595 [No Abstract] [Full Text] [Related]
14. Contributions to the optimal use of human blood. IX. Elimination of hepatitis B transmission by (potentially) infectious plasma derivatives. Stephan W Vox Sang; 1984; 46(6):421. PubMed ID: 6431692 [No Abstract] [Full Text] [Related]
15. Anti-HBc testing in an effort to reduce the incidence of posttransfusion non-A, non-B hepatitis. Kline WE Beitr Infusionther Klin Ernahr; 1987; 18():6-12. PubMed ID: 3125834 [No Abstract] [Full Text] [Related]
16. [Public Health Council advisory: prevention of post-transfusion non-A non-B hepatitis; is application of a surrogate test a missed station?]. Brandt KH Ned Tijdschr Geneeskd; 1989 Nov; 133(45):2212-4. PubMed ID: 2509949 [No Abstract] [Full Text] [Related]
17. [Guidelines for working with blood in Stockholm County]. Jordemodern; 1986 Jun; 99(6):216-7. PubMed ID: 3091547 [No Abstract] [Full Text] [Related]
18. [Anti-hepatitis C (HCV) ELISA. A serologic test for non-A non-B hepatitis (NANBH) after blood transfusion]. Orstavik I; Siebke JC; Rollag H; Skaug K; Størvold G; Orjasoeter H Tidsskr Nor Laegeforen; 1989 Dec; 109(34-36):3648. PubMed ID: 2515616 [No Abstract] [Full Text] [Related]
19. [Case of post-transfusion viral hepatitis of the non-A, non-B type]. Knap J; Karwowska S Pol Tyg Lek; 1982 Oct; 37(40):1209-10. PubMed ID: 6819554 [No Abstract] [Full Text] [Related]